日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

International guidelines on the diagnosis and treatment of NUT carcinoma

关于NUT癌诊断和治疗的国际指南

Zhang, Yu; Zhang, Qi; Hao, Yue; Luo, Jia; Piao, Yingshi; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Brcic, Luka; Liu, Aijun; Yu, Jinpu; Tsutani, Yasuhiro; Zhong, Wenzhao; Fang, Wenfeng; Wang, Zhijie; Ren, Shengxiang; Papavassiliou, Athanasios G; Zhang, Yongchang; Liu, Jingjing; Zhang, Shirong; Cai, Xiuyu; Cangir, Ayten Kayi; Liu, Anwen; Li, Wen; Lococo, Filippo; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Popper, Helmut; Chen, Yu; Yuan, Jingping; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Kairemo, Kalevi; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Leanne, Ashrafian; Li, Xiaoyan; Tang, Chuanhao; Siddique, Hifzur R; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Shelat, Vishal; Guo, Hui; Chu, Qian; Meng, Rui; Ardeshir, Fatemeh; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Kratzke, Robert A; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Calabrese, Fiorella; Xia, Yang; Mariani, Alessandro Wasum; Lu, Yuanyuan; Chen, Xiaofeng; Klein, Mark A; Ge, Rui; Dai, Enyong; Schönthal, Axel H; Han, Yu; Guo, Zhenying; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Chiappetta, Marco; Liu, Xuewen; Salle, Francoise Galateau; Yao, Yu; Szolkowska, Malgorzata; Pan, Weiwei; Pang, Fei; Wu, Fan; Watzka, Stefan B; Wang, Liping; Zhu, Youcai; Lin, Li; Sharma, Aparna; Tu, Jianfei; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Zauderer, Marjorie G; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Dudnik, Elizabeth; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Huang, Jianhui; Feng, Yue; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Baine, Marina K; Sun, Pingli; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Wu, Jing; Yang, Yunyun; Fang, Yuan; Wang, Zhen; Wan, Bin; Lv, Donglai; Chen, Huafei; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Sobeih, Mohamed Emam; Li, Bihui; Lian, Bin; Mao, Lili; Zhang, Zhang; Wang, Ke; Li, Zhongwu; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Miao; Wang, Guansong; Marron, Thomas U; Wang, Jiandong; Popat, Sanjay; Fang, Meiyu; Fang, Yong; Mansilla, Daniel; Li, Yuan; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Mansfield, Aaron S; Wang, Biyun; Si, Lu; Roden, Anja C; Grønberg, Bjørn H; Song, Yong; Shapiro, Geoffrey I; French, Christopher A; Lu, Yuanzhi; Wang, Qian; Xu, Chunwei

First-in-human study of DGPR1008 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer in patients undergoing radical prostatectomy

DGPR1008用于根治性前列腺切除术患者术中荧光成像以检测前列腺特异性膜抗原阳性前列腺癌的首次人体研究

Li, Peng; Xu, Ying; Yu, Shijie; Miao, Zhijun; Xu, Hongbo; Lu, Bing; Zhou, Shoujun; Gan, Wenjuan; Couñago, Felip; Kairemo, Kalevi; Vlachostergios, Panagiotis J; Zhao, Jing; Pu, Jinxian; Shen, Gang

Design of (225)Ac-PSMA for targeted alpha therapy in prostate cancer

针对前列腺癌的靶向α疗法设计(225)Ac-PSMA

Kairemo, Kalevi; Kgatle, Mankgopo; Bruchertseifer, Frank; Morgernstern, Alfred; Sathekge, Mike M

Sodium fluoride (Na(18)F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors

氟化钠(Na(18)F)PET实体瘤反应标准(NAFCIST):骨肿瘤反应评估框架

Kairemo, K; Gouda, M A; Buschhorn, L; Wahida, A; Macapinlac, H A; Anderson, P M; Subbiah, V

Androgen Receptor Imaging in the Management of Hormone-Dependent Cancers with Emphasis on Prostate Cancer

雄激素受体成像在激素依赖性癌症(以前列腺癌为例)管理中的应用

Kairemo, Kalevi; Hodolic, Marina

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma

帕唑帕尼在EWSR1-NFATC2易位相关骨肉瘤中的活性

Gouda, Mohamed A; Zarzour, Maria A; Vaporciyan, Ara A; Kairemo, Kalevi; Chuang, Hubert H; Subbiah, Vivek

A Retrospective Comparative Study of Sodium Fluoride Na(18)F-PET/CT and (68)Ga-PSMA-11 PET/CT in the Bone Metastases of Prostate Cancer Using a Volumetric 3-D Radiomic Analysis

回顾性比较氟化钠Na(18)F-PET/CT和(68)Ga-PSMA-11 PET/CT在前列腺癌骨转移中的应用:基于三维容积放射组学分析

Kairemo, Kalevi; Kangasmäki, Aki; Kappadath, Srinivasan Cheenu; Joensuu, Timo; Macapinlac, Homer A

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [(177)Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)

既往治疗作为接受 [(177)Lu]Lu-PSMA-617 治疗的转移性去势抵抗性前列腺癌患者总生存期的预后因素。一项 WARMTH 多中心研究(617 试验)

Ahmadzadehfar, Hojjat; Rahbar, Kambiz; Baum, Richard P; Seifert, Robert; Kessel, Katharina; Bögemann, Martin; Kulkarni, Harshad R; Zhang, Jingjing; Gerke, Carolin; Fimmers, Rolf; Kratochwil, Clemens; Rathke, Hendrik; Ilhan, Harun; Maffey-Steffan, Johanna; Sathekge, Mike; Kabasakal, Levent; Garcia-Perez, Francisco Osvaldo; Kairemo, Kalevi; Maharaj, Masha; Paez, Diana; Virgolini, Irene

(177)Lu-PSMA Radioligand Therapy Is Favorable as Third-Line Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

(177)Lu-PSMA放射性配体疗法作为转移性去势抵抗性前列腺癌患者的三线治疗方案具有优势。一项随机对照试验的系统评价和网络荟萃分析

von Eyben, Finn E; Kairemo, Kalevi; Paller, Channing; Hoffmann, Manuela Andrea; Paganelli, Giovanni; Virgolini, Irene; Roviello, Giandomenico

Radiomics Analysis for (177)Lu-DOTAGA-(l-y)fk(Sub-KuE) Targeted Radioligand Therapy Dosimetry in Metastatic Prostate Cancer-A Model Based on Clinical Example

基于临床实例的转移性前列腺癌(177)Lu-DOTAGA-(ly)fk(Sub-KuE)靶向放射性配体治疗剂量测定的放射组学分析模型

Kelk, Eve; Ruuge, Priit; Rohtla, Kristi; Poksi, Anne; Kairemo, Kalevi